Molina Healthcare (NYSE:MOH) Releases FY 2026 Earnings Guidance

Key Points

• Molina Healthcare guided to approximately $5.25 in FY 2026 EPS, just below the $5.26 analyst consensus, suggesting management largely maintained expectations.
• Third-quarter results beat estimates, with adjusted EPS of $0.89 versus $0.79 expected and revenue of $11.08 billion versus $10.86 billion. However, revenue declined 3.4% year over year, while net income and GAAP EPS fell substantially.
• Analyst sentiment remains cautious: the stock has a consensus “Hold” rating and a $208.06 average price target, while enrollment losses, Medicaid and Marketplace pressures, and Molina’s planned 2027 exit from traditional Medicare Advantage Part D remain key risks.

Molina Healthcare (NYSE:MOH - Get Free Report) updated its FY 2026 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 5.250- for the period, compared to the consensus earnings per share estimate of 5.260.

Wall Street Analysts Forecast Growth

MOH has been the subject of several recent analyst reports. Robert W. Baird set a $198.00 price objective on shares of Molina Healthcare in a research report on Friday. Weiss Ratings upgraded Molina Healthcare from a "sell (d)" rating to a "sell (d+)" rating in a research note on Wednesday. Wells Fargo & Company reduced their target price on Molina Healthcare from $235.00 to $220.00 and set an "equal weight" rating for the company in a report on Tuesday, July 28th. Cantor Fitzgerald restated a "neutral" rating on shares of Molina Healthcare in a research report on Friday, October 9th. Finally, Wall Street Zen lowered Molina Healthcare from a "hold" rating to a "sell" rating in a research note on Sunday, October 4th. Three analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $208.06.

Molina Healthcare Price Performance

NYSE MOH traded down $3.59 on Friday, reaching $213.05. 309,385 shares of the company's stock traded hands, compared to its average volume of 1,281,277. The stock has a 50-day simple moving average of $200.71 and a 200 day simple moving average of $196.06. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $244.89. The stock has a market cap of $11.12 billion, a PE ratio of -1,182.95, a P/E/G ratio of 30.81 and a beta of 0.78.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.51% and a negative net margin of 0.11%. The firm had revenue of $11.08 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same period in the previous year, the firm earned $1.84 earnings per share. The business's revenue was down 3.4% compared to the same quarter last year. As a group, research analysts predict that Molina Healthcare will post 5.28 earnings per share for the current year.

Key Molina Healthcare News

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Third-quarter results exceeded expectations. Adjusted EPS was $0.89 versus the $0.79 consensus estimate, while revenue reached $11.08 billion, above the $10.86 billion forecast. Molina Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management outlined an ambitious 2027 growth framework. Molina expects at least $45 billion of premium revenue, while its disclosed EPS building blocks total more than $9.50, offering investors a potential longer-term earnings catalyst. Molina 2027 Premium and EPS Outlook
• Positive Sentiment: Full-year adjusted earnings guidance was maintained near consensus. The updated 2026 EPS outlook of approximately $5.25 is only modestly below the $5.26 analyst estimate, reducing the risk of a major guidance cut.
• Neutral Sentiment: Revenue performance was mixed. Third-quarter sales topped estimates, but total revenue declined 3.4% year over year and premium revenue fell about 4%, reflecting lower enrollment. Molina Third-Quarter Results
• Negative Sentiment: Profitability deteriorated substantially. GAAP net income dropped to $38 million from $79 million a year earlier, while GAAP EPS fell to $0.73 from $1.51. The medical care ratio also increased to 92.9% from 92.6%, indicating cost pressure. Molina Posts Lower Third-Quarter Profit
• Negative Sentiment: Membership losses and business headwinds remain concerns. Lower Medicaid and Marketplace enrollment, pressure from the Florida Medicaid contract and the planned 2027 exit from traditional Medicare Advantage Part D could weigh on near-term results.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company's services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.